New Key Statistics Module, Z-Score and F-Score
OTCPK:CKLSF Key Ratios
| Market Cap $ M | 741.30 |
| Enterprise Value $ M | 1,562.25 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.33 |
| Price/Sales | 0.95 |
| Price/Free Cash Flow | 36.33 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 706.00 |
| EPS (TTM) $ | -0.002 |
| Beneish M-Score | -2.64 |
| 10-y EBITDA Growth Rate % | -0.90 |
| 5-y EBITDA Growth Rate % | -0.80 |
| y-y EBITDA Growth Rate % | 164.70 |
| EV-to-EBIT | 33.14 |
| EV-to-EBITDA | 26.54 |
| PEG | -- |
| Shares Outstanding M | 9,611.07 |
| Net Margin (%) | -1.17 |
| Operating Margin % | -0.21 |
| Pre-tax Margin (%) | 1.78 |
| Quick Ratio | 0.51 |
| Current Ratio | 0.91 |
| ROA % (ttm) | -0.55 |
| ROE % (ttm) | -1.71 |
| ROIC % (ttm) | -1.22 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.11 |
CKLSF Number of Guru Trades
CKLSF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CKLSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CKLSF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CK Life Sciences International Holdings Inc Insider Transactions
No Available Data
News about OTCPK:CKLSF
Total 0- 1